Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  3
 Total visitors :  8616301

Scientists Report First use of CRISPR to Substitute Genes to Treat Patients with Cancer
Friday, 2022/12/02 | 08:35:01

For the first time, scientists have used CRISPR gene editing technology to substitute a gene to treat patients with cancer. The new approach first identifies T cells that specifically recognize and kill an individual patient's tumor cells.

 

T cells are a type of immune cell, and the cells in question kill tumor cells when they encounter specific genetic mutations from cancer. However, there are often not enough of these cells. By CRISPR editing other T cells from the patient with the same cancer recognition motifs, the approach is designed to build a large army of cancer-fighting cells, which are then infused back into the patient, thus greatly amplifying that natural anti-tumor response.

 

The therapy approach was developed by PACT Pharma, based upon the work pioneered by Dr. Jim Heath, president of the Institute for Systems Biology (ISB), and his collaborators, UCLA Professor Dr. Toni Ribas and Caltech Professor Dr. David Baltimore. The therapy was used to treat 16 patients. The early-stage clinical trials were meant to show that the treatment was safe for patients, but the researchers also found that the engineered T cells did, in fact, home in on the patient tumors.

 

“This is a leap forward in developing a personalized treatment for cancer,” Ribas said. “The generation of a personalized cell treatment for cancer would not have been feasible without the newly developed ability to use the CRISPR technique to replace the immune receptors in clinical-grade cell preparations in a single step,” he added.

 

To learn more about this research, read the article on the ISB website, or watch this YouTube video.

https://www.isaaa.org/kc/cropbiotechupdate/ged/article/default.asp?ID=19871

 

Back      Print      View: 281

[ Other News ]___________________________________________________
  • Australia`s Gene Regulator OGTR Invites Comments on Field Trial of GM Perennial Ryegrass
  • Long Lost Chromosome Increases Nitrogen Efficiency of Modern Maize
  • Modified Agrobacterium Strain Useful for Switchgrass Transformation
  • Study Reveals Role of Soybean 14-3-3 Gene on White Mold Resistance
  • CIMMYT Study Says Breeding New Crops Must Adapt to Climate Change
  • Researchers Identify Genes to Help Fruit Adapt to Droughts
  • Kenyans Need to Turn to GM Crops to Combat Drought
  • 28-Million-Year-Old Gene Protects Plants Against Caterpillars
  • Agronomists Find Wheat Varieties Resistant to Enzyme Depletion
  • Root Structure Mapped Out to Identify Components of Drought Stress Tolerance in Rice
  • Large Chinese Seed Companies Likely to Produce Gene-Edited Crops for Farmers – Study
  • Study Finds CRISPR-Cas9 Leads to Unexpected Genomic Changes
  • Plants Yield Better When Grown Among Genetically Similar Plants
  • Codex Alimentarius: FAO Director-General stresses key role of science and data in the Commission`s work
  • World Food Programme and ICRISAT: working to improve nutrition and build resilience in vulnerable communities
  • From Lab to Farm: Scientific research and its contribution to family farming and rural entrepreneurship
  • Chemists Create Artificial Photosynthesis 10 Times More Efficient than Existing Systems
  • Micro/Nanofluidics and Lab-on-Chip Based Emerging Technologies for Biomedical and Translational Research Applications - Part B
  • Scientists Identify Wheat Genetically Resistant to Fungus Causing Snow Mold
  • Antimicrobial resistance: Now is the time for collective action

 

Designed & Powered by WEBSO CO.,LTD